Guggenheim Starts Assembly Biosciences (ASMB) at Buy
Tweet
Share
E-mailGet Alerts ASMB Hot Sheet
Price: $26.80 --0%
Rating Summary:
7 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 6 | New: 25
Rating Summary:
7 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 6 | New: 25
Join SI Premium – FREE
Guggenheim analyst Vamil Divan initiates coverage on Assembly Biosciences (NASDAQ: ASMB) with a Buy rating and a price target of $31.00.
For an analyst ratings summary and ratings history on Assembly Biosciences click here. For more ratings news on Assembly Biosciences click here.
Shares of Assembly Biosciences closed at $11.12 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barrington Research Starts CBIZ, Inc. (CBZ) at Outperform
- Arm Holdings (ARM) PT Raised to $470 at UBS on Raised Revenue Estimates
- Korn/Ferry (KFY) PT Raised to $75 at UBS on Q4 Revenue/EBITDA Upsides
Create E-mail Alert Related Categories
New CoverageRelated Entities
Maynard Um, Guggenheim, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
